Clinical Trial

Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Airway Stenosis

Active, Not Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this Prospective Trial of Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Airway Obstruction (OXYGEN-1) is to evaluate clinical safety and potential efficacy of the Airiver Pulmonary DCB in the treatment of benign central airway stenosis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-05-31.
Status change: Recruiting → Active, Not Recruiting 2025-12-08
Trial Details
NCT Number NCT05895305
Lead Sponsor Airiver Medical, Inc.
Collaborators: Libra Medical
Conditions Central Airway Obstruction
Enrollment 45 participants
Start Date 2023-05-16
Primary Completion 2025-10-04 (estimated)
Study Completion 2029-10-04 (estimated)
Updated on ClinicalTrials.gov 2025-12-15